Antiestrogen fulvestrant enhances the antiproliferative effects of epidermal growth factor receptor inhibitors in human non-small cell lung cancer

Eitemau Tebyg

• Identification of common predictive markers of in vitro response to the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in human breast cancer and non-small cell lung cancer cell lines
  gan: Garon, Edward B., et al.
  Cyhoeddwyd: (2010)
• The HSP90 inhibitor NVP-AUY922 potently inhibits non-small cell lung cancer growth
  gan: Garon, Edward B., et al.
  Cyhoeddwyd: (2013)
• Dichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather than as a single agent in advanced non-small cell lung cancer
  gan: Garon, Edward B., et al.
  Cyhoeddwyd: (2014)
• Antiestrogens in combination with immune checkpoint inhibitors in breast cancer immunotherapy
  gan: Márquez-Garbán, Diana C., et al.
  Cyhoeddwyd: (2019)
• Randomized Phase II Study of Fulvestrant and Erlotinib Compared With Erlotinib Alone in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer
  gan: Garon, Edward B., et al.
  Cyhoeddwyd: (2018)